Improvement of Facial Nerve Monitoring in Parotid Surgery by Sugammadex
NCT ID: NCT02314234
Last Updated: 2016-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2012-01-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Efficacy and Safety of Sugammadex and Neostigmine
NCT04997759
Role of Sugammadex and Neostigmine for Recovery From Rocuronium
NCT06432621
Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)
NCT00451217
Sugammadex and Time to Extubation in Ophthalmic Surgery
NCT06632067
The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery
NCT06334562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
did not receive muscle relaxant during anesthesia
No interventions assigned to this group
Sugammadex group
received single dose of rocuronium for anesthesia and sugammadex at skin incision
sugammadex (Bridion)
single dose of sugammadex at skin incision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sugammadex (Bridion)
single dose of sugammadex at skin incision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
I-Cheng Lu
Visiting staff
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I-Cheng Lu
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMUH-IRB-20140248
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.